MSPR Downgraded to OTC Expert Market Due to Non-Compliance, Severely Restricting Trading
MSPR sits 81% above its 52-week low of $0.011.
Summary
MSP Recovery, Inc. announced its securities will be moved to the OTC Expert Market on July 17, 2026, due to its failure to file required financial reports, severely limiting public trading access.
Key Events · Legal and Risk Events · MSPR
-
Trading Restriction Imminent
MSP Recovery's Class A common stock and publicly traded warrants will be moved from OTC Pink Limited Information to the OTC Expert Market on or around July 17, 2026.
-
Non-Compliance Driving Downgrade
The downgrade is a direct result of the company's failure to file its Annual Report on Form 10-K for 2025 and Quarterly Report on Form 10-Q for Q1 2026.
-
Limited Trading Access
The Expert Market only allows unsolicited quotes, restricting trading primarily to broker-dealers, institutions, and sophisticated investors, severely limiting retail investor access and liquidity.
-
No Expected Compliance by Deadline
The company does not expect to file the delayed reports by the July 17, 2026 deadline, indicating a prolonged period of non-compliance and restricted trading.
Analysis · MSPR · Technology
MSP Recovery, Inc. faces a critical blow as its securities are set to move to the OTC Expert Market on July 17, 2026. This downgrade is a direct consequence of the company's failure to file its 2025 Annual Report and Q1 2026 Quarterly Report. Trading on the Expert Market is severely restricted, allowing only unsolicited quotes from sophisticated investors, effectively cutting off most retail investor access and liquidity. The company explicitly stated it does not expect to regain compliance by the deadline, signaling a prolonged period of limited trading and deepening governance issues. This follows a series of disclosures about liquidity crises and previous downgrades, indicating severe financial and operational distress.
At the time of this filing, MSPR was trading at $0.02 on OTC in the Technology sector, with a market capitalization of approximately $283.6K. The 52-week trading range was $0.01 to $59.29. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.